Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Horsman

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Acta Oncologica (Stockholm, Sweden)|January 1, 1995
Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. A reviewM R Horsman
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 12, 2007
Hyperthermia: a potent enhancer of radiotherapyM R Horsman, J Overgaard
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|June 19, 2004
Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acidR Murata, M R Horsman
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 1, 1997
Can mild hyperthermia improve tumour oxygenation?M R Horsman, J Overgaard
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|September 19, 2013
Relevance of hypoxia in radiation oncology: pathophysiology, tumor biology and implications for treatmentM Busk, M R Horsman
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 1, 1992
BW12C-induced changes in haemoglobin-oxygen affinity in mice and its influence on the radiation response of a C3H mouse mammary carcinomaM R Horsman, J Overgaard
Acta Oncologica (Stockholm, Sweden)|January 1, 1989
Vascular effects of photodynamic therapy in an intraocular retinoblastoma-like tumourM R Horsman, J Winther
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Tumor blood flow changes induced by chemical modifiers of radiation responseD J Chaplin, M R Horsman
Laboratory Animals|October 4, 2005
Experience with mouse hepatitis virus sanitation in three transplantable murine tumour linesF Dagnaes-Hansen, M R Horsman
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|November 27, 2007
The new vascular disrupting agent combretastatin-A1-disodium-phosphate (OXi4503) enhances tumour response to mild hyperthermia and thermoradiosensitizationS L Hokland, M R Horsman
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Acta Oncologica (Stockholm, Sweden)|January 1, 1995
Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. A reviewM R Horsman
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 12, 2007
Hyperthermia: a potent enhancer of radiotherapyM R Horsman, J Overgaard
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|June 19, 2004
Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acidR Murata, M R Horsman
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 1, 1997
Can mild hyperthermia improve tumour oxygenation?M R Horsman, J Overgaard
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|September 19, 2013
Relevance of hypoxia in radiation oncology: pathophysiology, tumor biology and implications for treatmentM Busk, M R Horsman
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 1, 1992
BW12C-induced changes in haemoglobin-oxygen affinity in mice and its influence on the radiation response of a C3H mouse mammary carcinomaM R Horsman, J Overgaard
Acta Oncologica (Stockholm, Sweden)|January 1, 1989
Vascular effects of photodynamic therapy in an intraocular retinoblastoma-like tumourM R Horsman, J Winther
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Tumor blood flow changes induced by chemical modifiers of radiation responseD J Chaplin, M R Horsman
Laboratory Animals|October 4, 2005
Experience with mouse hepatitis virus sanitation in three transplantable murine tumour linesF Dagnaes-Hansen, M R Horsman
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|November 27, 2007
The new vascular disrupting agent combretastatin-A1-disodium-phosphate (OXi4503) enhances tumour response to mild hyperthermia and thermoradiosensitizationS L Hokland, M R Horsman
Pageof 11